ANALYSIS OF CHANGES IN LIVER ENZYMES UNDER THE INFLUENCE OF ANTIVIRAL DRUGS IN PATIENTS WITH COVID-19
Keywords:
Covid-19, favipiravir, remsidivir, ALT, AST.Abstract
This article told about 110 patients who were treated in June 2021 at the Republican Special Hospital No. 2 of Zangiot, where the diagnosis of coronavirus was confirmed. In general, Covid- 19 of mild and moderate severity was detected in patients. The patients underwent a standard course of treatment on the recommendation of WHO. The standard treatment plan includes medications like favipiravir and remsidivir. A biochemical blood test was performed every three days, and changes in the analysis were dynamically monitored. It was found that patients mainly had liver disorders, especially ALT and AST were 2 and 3 times higher than normal. At the end of the course of treatment with antiviral drugs, a slow decrease in the level of enzymes was observed.
References
Desai MK. Pharmacovigilance and assessment of drug safety reports during COVID 19. Perspect Clin Res. 2020;11(3):128. DOI:10.4103/picr.PICR_171_20
Singh TU, Parida S, Lingaraju MC, et al. Drug repurposing approach to fight COVID-19. Pharmacol Rep. 2020;72:1479-508. DOI:10.1007/s43440-020-00155-6
World Health Organization. Rolling updates on coronavirus disease (COVID-19)(Updated18April2020). https://www.who.int/emergencies/diseases/novel-coro-navirus-2019/events-as-they-happen. Accessed Apr 21, 2020.
